Orofacial pain and oral medicine
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University
Special Issue in Periodicals
Selected peer-reviewed papers
Prof. Hsiu-Hsi Chen is an expert in evaluation of intervention program, with emphasis on population-based cancer screening and also universal vaccination program, by using a series of complex statistical modelling to deal with several thorny issues that cannot be solved by classical approaches. These include the development of different health economic decision models for cancer screening program and also vaccination program and prophylactic treatment. The recent statistical publications on the methodology of applying stochastic process to evaluation of cancer screening model published in JASA, Biometrics, and other peer review articles. A series of original articles cost-effectiveness (benefit) analysis based on these models have been published in international peer review articles.
Regarding international academic cooperation, Professor Chen has taken the presidency of the international Asian Cancer Screening Conference (Network) held annually since 2004. As far as collaborative research in Western countries is concerned, the long-lasting collaboration with Sweden (Falun Central Hospital), the USA (American Cancer Society), United Kingdom (Wolfson Institute of Preventive Medicine), and also Finland (School of Public Health, University of Tampere) where Professor Chen was awarded the Finland Distinguished Professor (FIDIPRO) issued by the Academy of Finland between 2007 and 2009.
Professor in Tumour Pathology
University of Bergen
Oral cancer: tumour-stroma interactions in oral squamous cell carcinoma
I am trained as an oral pathologist. Since year 2000 I perform research in the field of oral epithelial biology and cancer and since 2011 I also carry out surgical pathological diagnostic in oral and ear-nose-throat areas. Later on, I became interested in biomarkers and since 2016 I am Associated Investigator at Center of Excellency in Cancer Biomarkers CCBIO. CCBIO is one of the most prestigious centers of cancer research in Norway, financed by Norwegian Research Council (NFR) (https://www.uib.no/en/ccbio/107681/daniela-elena-costea ). My research interests follow two lines: an experimental one, in which I use in vitro and in vivo humanized models of normal human oral mucosa and oral cancer for deciphering the key molecular interactions between oral epithelial cells, be they normal or neoplastic, and their microenvironment; and a descriptive one, in which I use various biological samples to characterize as thorough as possible the lesions of oral cancer and the host, with the aim of identifying a method for effective stratification of cancer patients according to the biological progress and outcome of their disease (http://patexp.w.uib.no/). I have been PI or co-Investigator of several national- and EU-funded grants.
Professor & Executive Director
Australian Centre for Oral Oncology Research & Education, Australian Clinical Labs, CQUniversity, and Peter MacCallum Cancer Centre
Oral Medicine, Oral Pathology, Oral Cancer, Oral Potentially Malignant Disorders
Professor Camile S. Farah BDSc, MDSc (OralMed OralPath), PhD, GCEd (HE), GCExLead, MBA, MAICD, AFCHSM, CHM, FRACDS (OralMed), FOMAA, FIAOO, FICD, FPFA, FAIM is a highly accomplished executive, academic, researcher and author with 25 years’ experience in the healthcare, biotech and medical research sectors. He is dual trained oral physician and maxillofacial pathologist, with public and private appointments at Fiona Stanley Hospital, Hollywood Private Hospital, Qscan Radiology Clinics, Australian Clinical Labs, Genomics for Life, and Optiscan Imaging Ltd. Currently he is Adjunct Professor at CQUniversity and Honorary Professorial Research Fellow at the Peter MacCallum Cancer Centre. His clinical and research expertise lie in optical imaging, molecular pathology and precision medicine in head and neck cancer. Professor Farah is a leading international expert in oral cancer and precancerous pathology based on his clinical and research expertise having attracted $19.5 million in competitive research funding, published 250 papers and a bestselling textbook “Contemporary Oral Medicine” with a H-index of 45. He has mentored over 50 postgraduate students, registrars and postdoctoral fellows. He is former Dean and Professor of Oral Oncology at the University of Western Australia Dental School, former Chair of the Australian Dental Research Foundation, former President of the Oral Medicine Academy of Australasia, and former President of the Asia Pacific Region and ANZ Division of the International Association for Dental Research.
Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University
University of Malaya
29/03/2004: ERALA UNIVERSITY, INDIA. MDS (Oral Pathology)
23/03/1998: AMIL NADU Dr. M.G.R. MEDICAL UNIVERSITY. BDS
24/08/2018 - (Lifetime Membership): Malaysian Society of Oral Microbiologists and Oral Immunologists
Department of Oral Pathology, School of Dentistry, Pusan National University
University of Chicago
Dr. Mark Lingen is a Professor of Pathology and Medicine at the University of Chicago Medicine. He is a graduate of Northwestern University Dental School. He also completed a residency in Oral & Maxillofacial Pathology and earned a PhD in Cellular and Molecular Pathology at Northwestern University. Dr. Lingen is the Editor-in-Chief for the journal Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology (Triple O). He is a Fellow of the American Academy of Oral & Maxillofacial Pathology, the American and International Colleges of Dentists, and the Royal College of Pathologists. Dr. Lingen is a Diplomate of the American Board of Oral & Maxillofacial Pathology. He is a Past President of the American Academy of Oral & Maxillofacial Pathology (AAOMP) and the current President of the International Association of Oral & Maxillofacial Pathology (IAOP). Dr. Lingen’s NIH-funded research, which focusses on several aspects of oral cancer, has resulted in more than 200 manuscripts and book chapters.
Department of Oral Pathology/Forensic Odontology, School of Dentistry, Aichi Gakuin University
Oral Pathology and Oral Medicine
Assistant Professor, University of Toronto
Staff oral pathologist, Sunnybrook Health Sciences Centre
Cancer cell biology
Dr. Marco Magalhaes is a clinician-scientist, director of the Cancer Invasion and Metastasis Laboratory (CIMlab) and assistant professor at the Faculty of Dentistry, cross-appointed to Laboratory Medicine and Pathology and Institute of Medical Sciences, Faculty of Medicine. Dr. Magalhaes received his PhD in cell biology at the University of Toronto in 2009 and completed a postdoctoral fellowship at the Albert Einstein College of Medicine Cancer Centre before returning to the University of Toronto to complete his residency in Oral Pathology and Oral Medicine. Dr. Magalhaes currently has several research projects in the area of oral potentially malignant disorders and oral cancer and is a staff oral pathologist at Sunnybrook Health Sciences Centre. His main area of interest is the role of immune cells and mediators in the progression of oral cancer. He is a Diplomate of the American Board of Oral and Maxillofacial Pathology, fellow of the American Academy of Oral and Maxillofacial Pathology, and a Fellow of the Royal College of Dentists of Canada.
Honorary Consultant Histopathologist and Emeritus Professor of Oral Pathology and Medicine
Guy’s and St Thomas’ NHS Trust and King’s College London
Oral and Maxillofacial Pathology
Studied dentistry at the Royal London Medical College, PhD University College London, Pathology training at Guy’s Hospital London
I have worked in Oral and Maxillofacial Pathology since 1982 and been Head of Department at Guy’s and St Thomas’ Hospitals since 2005. I have worked in both Oral Pathology and Oral Medicine.
President International Association of Oral and Maxillofacial Pathologists 2018-2020
Prof Odell has been extensively involved nationally in education, assessment and regulation of the specialty of oral pathology and dental undergraduate education. He is author of several textbooks including Cawson’s Essentials of Oral Pathology and Medicine. He has particular interest in dysplasia and odontogenic tumours and has been involved in the last three editions of the WHO International classification of diseases as author, a member of the consensus group and currently a member of the specialist editorial panel. He has published over 180 peer-reviewed research publications and five textbooks. He was lead tumour board pathologist for the Guy’s and St Thomas’ NHS Trust for Head and Neck Pathology until 2016.
Department of Oral Pathology, School of Dentistry, Pusan National University
Oral Pathology, oral cancer, association between periodontitis and systemic diseases
2006: Best researcher awards, Association of Oral and Maxillofacial Pathology
Hae Ryoun Park graduated from School of Dentistry, Pusan National University in 1991 and got a Ph.D degree from the same university in 1995. HR Park has been teaching oral pathology since 1998. Interest of studies are effects of chronic periodontitis on oral cancer progression including invasive and metastatic abilities. In addition, Hae Ryoun Park is leading a seven-year, $ 9.5 million Medical Research Center program of Basic Science Research Grant funded by the National Research Foundation of Korea. The research team is investigating the role of periodontal pathogens, especially Porphyromonas gingivalis, in the development of various systemic diseases as well as the correlation between chronic periodontitis and systemic diseases.
The University of British Columbia
Oral Pathology/ Oral Medicine
Professor & Head of the Department of Oral and Maxillofacial Pathology, Ragas Dental College, Chennai
Oral Cancer, Pre-cancer, OSF, HIV, Stem cell research
IAOP President’s Prize Lectures
University of Hong Kong
DSc (hon), FRCPath, FHKCPath, FDSRCS (Edin) FRACDS, FDS RCPS
Professor emeritus and Immediate-past Dean, Faculty of Dentistry, University of Hong Kong
Fakhruddin, KS , Samaranayake, LP, Hamoudi, RA et al Hien Chi (2022) Diversity of site-specific microbes of occlusal and proximal lesions in severe- early childhood caries (S-ECC), Journal of Oral Microbiology, 14:1, DOI: 10.1080/20002297.2022.2037832
Samaranayake, LP, Seneviratne, CJ, Fakhruddin, KS. (2022) Coronavirus disease 2019 (COVID-19) vaccines: A concise review. Oral Dis; 28(Suppl. 2): 2326– 2336. https://doi.org/10.1111/odi.13916
Samaranayake, L P; Kausar S. Fakhruddin, Hien C. Ngo, H.M.N.M. Bandara, Y.Y. Leung, (2022) Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review, International Dental Journal,; 72: 607-620
Seneviratne, C., Jin, L. and Samaranayake, L. (2008), Biofilm lifestyle of Candida: a mini review. Oral Diseases, 14: 582-590. https://doi.org/10.1111/j.1601-0825.2007.01424.x
Bandara, MHMN A Hewavitharana, PN Shaw H Smyth, Samaranayake LP (2020) A novel, quorum sensor-infused liposomal drug delivery system suppresses Candida albicans biofilms. International Journal of Pharmaceutics. 578. 119096. 10.1016/j.ijpharm.2020.119096.
Professor Emeritus Lakshman `Sam` Samaranayake of the University of Hong Kong, is a renowned clinical academic with expertise in clinical microbiology, research, and executive level administration, and has worked in five different universities in UK, Canada, Hong Kong, Australia, and UAE. With a current h-index of 99, he is the author of over 450 publications, including seminal texts, that have been cited over 31,000 occasions. Being the current Editor-in-Chief of the International Dental Journal. Professor Samaranayake has served over 12 years as the Executive Dean of two major dental schools in Hong Kong and Australia at the Universities of Hong Kong, and Queensland, respectively. A highly sought-after speaker, he has addressed professional bodies in over 40 countries, and received numerous prestigious accolades for his contributions to dentistry, oral medicine and pathology including the coveted King James IV Professorship of the Royal College of Surgeons of Edinburgh, UK, and the Distinguished Scientist Award of IADR, USA.
Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Malaysia
Oral Pathology, Oral Cancer, Oral Potentially Malignant Disorders
Professor WM Tilakaratne BDS, MS, FDSRCS, FRCPath, PhD is currently a Professor attached to the Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya and Department of Oral Pathology, University of Peradeniya. After completing BDS from university of Peradeniya, Sri Lanka he obtained his MS degree from University of Colombo. Then he obtained his professional qualifications from United Kingdom and PhD from University of Niigata, Japan. He has been working as an Oral Pathologist for three decades and held many positions in the field of Oral Pathology. He is a past president of the International Association of Oral Pathologists. He has worked as the Professor of Oral Pathology at Queen Mary University of London and a visiting Professor to many universities in different countries. He was the former Dean and Senior Professor of Oral Pathology, Faculty of Dental Sciences, University of Peradeniya Sri Lanka. Professor Tilakaratne’s main research field is Oral cancer and Oral potentially malignant disorders. He has published over 145 papers with a H-index of 34 and written a text book and contributed to many chapters in internationally recognized text books. He is an editorial board member for many journals as well as for the latest WHO classification on Head and tumours.
Full Professor in Oral Pathology
Tel Aviv University
Odontogenic tumors and cysts, Microenvironment of oral cancer
In charge of Oral Pathology service, School of Dental Medicine,
Tel Aviv University & Institute of Pathology, The Chaim Sheba Medical Center, Tel Hashomer, Israel
Rector of Tel Aviv University award for outstanding teaching
Marilena Vered obtained her dental degree (DMD) in 1992 at the Faculty of Dentistry, at the Hebrew University in Jerusalem. In 2001 she completed the Oral Pathology training program at the Department of Oral Pathology, Oral Medicine and Maxillofacial Imaging, at the School of Dentistry at Tel Aviv University. She is in charge of the service of oral pathology at the School of Dentistry and at Sheba Medical Center at Tel Hashomer. She has co-authored over 100 articles in international peer-reviewed journals and serves as a reviewer for most of the leading journals in the field of oral pathology and oral medicine. She has been interested in investigating challenging odontogenic lesions and the microenvironment of oral cancer and collaborated with leading researchers in these fields.
Division of Oral Pathology, Niigata University Graduate School of Medical and Dental Sciences
Department of Oral Pathology, Oral Cancer Research Institute
College of Dentistry Yonsei University
Oral Pathology, Oral Cancer
Section of Pathology, Department of Morphological Biology,
Division of Biomedical Sciences, Fukuoka Dental College
Chung Shan Medical University
Oral Cancer/Oral Submucous Fibrosis